NCT04876352

Brief Summary

The aim of this study is to assess the effect of 8-week physiotherapy training using immersive virtual reality (VR-training) compared to a physiotherapy training performed in a real setting (RS-training) on handwriting and touch screen technology-based activities, brain functional activity and cognition in patients with Parkinson's disease (PD). Both groups will perform upper limb exercises focused at improving movement amplitude and speed during several activities such as writing and using touch screen-technology. Participants randomized to VR-training (N=20) will perform exercises under the augmented visual feedback induced by the VR aimed at stimulating movement amplitude and speed. Participants randomized to RS-training (N=20) will perform exercises in a real setting. Before training, after training (8 weeks) and at 3-month follow-up (20 weeks), subjects with PD will undergo clinical evaluations (neurological, physiotherapy and neuropsychological) while taking their regular anti-parkinsonian drugs (on-medication state). MRI scans will be acquired at each time-point to assess brain activity reorganization during off state (MRI scans will be acquired at least 12 hours after the regular evening dopaminergic therapy administration to mitigate the pharmacological effects on neural activity). A sample of matched healthy subjects (N=30) will undergo clinical, physiotherapy, neuropsychological and MRI assessments only at study entry as a benchmark.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P75+ for not_applicable parkinson-disease

Timeline
Completed

Started May 2021

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 6, 2021

Completed
11 days until next milestone

Study Start

First participant enrolled

May 17, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 6, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2024

Completed
Last Updated

April 8, 2025

Status Verified

April 1, 2025

Enrollment Period

3.3 years

First QC Date

May 3, 2021

Last Update Submit

April 7, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Letters amplitude

    Changes in letters amplitude during a repetitive handwriting task on a writing tablet. Higher amplitude reflects a better performance. Assessment during ON medication phase

    Baseline, after 8 weeks of training and after 3-month follow-up

Secondary Outcomes (15)

  • Systematic Screening of Handwriting Difficulties test (SOS)

    Baseline, after 8 weeks of training and after 3-month follow-up

  • Systematic Screening of Handwriting Difficulties test (SOS) on a tablet

    Baseline, after 8 weeks of training and after 3-month follow-up

  • Repetitive Prewriting task on tablet

    Baseline, after 8 weeks of training and after 3-month follow-up

  • Funnel task on tablet

    Baseline, after 8 weeks of training and after 3-month follow-up

  • Brain functional changes during hand-tapping in a virtual reality setting

    Baseline, after 8 weeks of training and after 3-month follow-up

  • +10 more secondary outcomes

Study Arms (3)

VR-training

EXPERIMENTAL

Upper limb/handwriting exercises in an immersive virtual reality setting

Other: Upper limb/handwriting exercises in an immersive virtual reality setting (VR-training)

RS-training

ACTIVE COMPARATOR

The same upper limb/handwriting exercises in a real setting

Other: Upper limb/handwriting exercises in a real setting (RS-training)

Healthy subjects

OTHER

Age- and sex-matched healthy subjects recruited to compare clinical and fMRI characteristics at baseline.

Other: No intervention

Interventions

Progressively difficult multimodal physiotherapy under the augmented visual feedback induced by the VR. Participants will wear a head-mounted display and their upper limb movements during the training will be captured by a motion tracker. Patients will perform: repetition of movements of upper limb single joints (shoulder, elbow and wrist) under the augmented visual feedback provided by the use of VR in increasingly wide range of movement; active upper limb multi-joints movements under the augmented visual feedback provided by the use of VR (following trajectories designed in the virtual space - movement involving shoulder, elbow and wrist joints) and handwriting tasks and touch screen technology usage in VR context on a tablet and a smartphone. 30 minutes of exercises, 2 times a week, for 8 weeks.

VR-training

Participants will perform progressively difficult multimodal physiotherapy in a real setting. Participants will be encouraged to perform their upper limb movements during the training in order to perform faster and ampler movements. They will perform: repetition of movements of upper limb single joints (shoulder, elbow and wrist) in increasingly wide range of movement under the feedback provided by therapist; active upper limb multi-joints movements under the feedback provided by the therapist (following trajectories designed on a table or on a blackboard - movements involving shoulder, elbow and wrist joints) and handwriting tasks and touch screen technology usage under the supervision of the therapist. 30 minutes of exercises, 2 times a week, for 8 weeks.

RS-training

Only baseline evaluations, without longitudinal assessment

Healthy subjects

Eligibility Criteria

AgeUp to 85 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of idiopathic Parkinson's disease
  • H\&Y scale ≤ 3 while on medication
  • Age ≤ 85 years
  • Right-handedness with the Edinburgh Handedness Inventory Quotient
  • Right-side involvement according to H\&Y and Movement Disorder Society Unified Parkinson's Disease Rating Scale III (MDS-UPDRS III)
  • Handwriting difficulty defined by a score greater than or equal to 1 on item II.7 of the MDS-UPDRS
  • Oral and written informed consent to study participation
  • Sex-matched and age-matched with PD patients;
  • Right-handed;
  • Oral and written informed consent to study participation.

You may not qualify if:

  • Mini-Mental State Examination lower than 24;
  • Visual impairments that interfere with the immersive virtual environment;
  • (Other) upper limb deficits impeding handwriting;
  • History of (other) systemic, neurologic, psychiatric diseases, head injury and cerebrovascular alterations visible at an MRI scan;
  • Family history of neurodegenerative disorders;
  • History of alcohol and/or psychotropic drug abuse;
  • Contraindications for MRI;
  • Denied oral and written informed consent to study participation.
  • Mini-Mental State Examination lower than 28;
  • Visual impairments that interfere with the immersive virtual environment;
  • History of systemic, neurologic, psychiatric diseases, head injury and cerebrovascular alterations visible at an MRI scan;
  • History of alcohol and/or psychotropic drug abuse;
  • Contraindications for MRI;
  • Denied oral and written informed consent to study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS San Raffaele

Milan, 20132, Italy

Location

Related Publications (1)

  • Corbetta D, Sarasso E, Gardoni A, Zenere L, Balestrino R, Smits-Engelsman B, Pelosin E, Filippi M, Agosta F. Construct validity, intrarater and interrater reliability of the Italian version of the systematic screening of handwriting difficulties (SOS) test in people with Parkinson's disease. J Neurol. 2025 Sep 8;272(9):620. doi: 10.1007/s00415-025-13365-w.

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Physiotherapist, neurologists, neuropsychologists and radiologist assessing the patients are blinded to group allocation.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Single-blind randomized controlled trial. 40 PD patients are randomly divided into two groups: 20 in the VR-training (experimental) and 20 in the RS-training (active comparator). The assessors are blinded to the group allocation. In addition, a group of 30 healthy age- and sex-matched control is included at baseline
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 3, 2021

First Posted

May 6, 2021

Study Start

May 17, 2021

Primary Completion

September 6, 2024

Study Completion

September 6, 2024

Last Updated

April 8, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations